title: Pityriasis rosea following influenza (H1N1) vaccination.
abstract: Pityriasis rosea is a distinct papulosquamous skin eruption that has been attributed to viral reactivation, certain drug exposures or rarely, vaccination. Herein, we reported a clinicopathlogically typical case of pityriasis rosea that developed after the H1N1 vaccination. With a global H1N1 vaccination program against the pandemic H1N1 influenza, patients should be apprised of the possibility of such rare but benign skin reaction to avoid unnecessary fear. Furthermore, a brief review of the current reported skin adverse events related to the novel H1N1 vaccination in Taiwan is presented here.
authors.affiliation: Department of Dermatology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
authors.forename: Jeng-Feng
authors.initials: JF
authors.lastname: Chen
authors.forename: Chien-Ping
authors.initials: CP
authors.lastname: Chiang
authors.forename: Yu-Fei
authors.initials: YF
authors.lastname: Chen
authors.forename: Wei-Ming
authors.initials: WM
authors.lastname: Wang
mesh_terms: D000328:Adult; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000009:adverse effects*; D008297:Male; D017515:Pityriasis Rosea / Q000209:etiology*
chemical_list: D007252:Influenza Vaccines